Literature DB >> 11435175

Carcinoma of the hard palate treated with radiotherapy: a retrospective review of 31 cases.

A Yorozu1, A J Sykes, N J Slevin.   

Abstract

There are few studies reporting the results of radical radiotherapy for carcinoma of the hard palate. We have examined our results of patients treated within a single institution, and assessed survival, local control and morbidity. A retrospective analysis was made on 31 patients with hard palate carcinoma treated with external beam radiotherapy at the Christie Hospital between 1990 and 1997. Twenty-six patients received radiotherapy alone and five were treated for post-operative positive surgical margins. The 5-year actuarial survival rate was 55%. The actuarial 5-year local control rate was 53%, rising up to 69% after salvage surgery. Survival was 48% for squamous cell carcinomas and 63% for salivary gland carcinomas, the difference was not significant. The only significant predictor of local control was T-stage, with 80% 5-year local control of T1-2 lesions and 24% control of T3-4 lesions. N-stage was the only significant factor predicting for survival. Radiation necrosis occurred in one patient. Radical radiotherapy for carcinoma of the hard palate is safe and well tolerated. It is an effective treatment for both squamous cell carcinoma and salivary gland carcinoma.

Entities:  

Mesh:

Year:  2001        PMID: 11435175     DOI: 10.1016/s1368-8375(00)00136-6

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  9 in total

1.  Radiation therapy in the treatment of minor salivary gland tumors.

Authors:  Lucas R Salgado; Daniel E Spratt; Nadeem Riaz; Paul B Romesser; Suzanne Wolden; Shyam Rao; Christine Chin; Julian C Hong; Richard Wong; Nancy Y Lee
Journal:  Am J Clin Oncol       Date:  2014-10       Impact factor: 2.339

2.  Is elective neck dissection needed in clinically N0 neck in maxillary cancer?

Authors:  Hong-Ju Park
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2014-06

3.  Multicenter study of carbon-ion radiation therapy for nonsquamous cell carcinomas of the oral cavity.

Authors:  Hiroaki Ikawa; Masashi Koto; Yusuke Demizu; Jun-Ichi Saitoh; Hiroaki Suefuji; Tomoaki Okimoto; Tatsuya Ohno; Yoshiyuki Shioyama; Ryo Takagi; Kazuhiko Hayashi; Kenji Nemoto; Takashi Nakano; Tadashi Kamada
Journal:  Cancer Med       Date:  2019-08-01       Impact factor: 4.452

4.  Feasibility of carbon-ion radiotherapy for oral non-squamous cell carcinomas.

Authors:  Hiroaki Ikawa; Masashi Koto; Kazuhiko Hayashi; Morio Tonogi; Ryo Takagi; Takeshi Nomura; Hiroshi Tsuji; Tadashi Kamada
Journal:  Head Neck       Date:  2019-01-24       Impact factor: 3.147

5.  Elective neck dissection (END) and cN0 hard palate and upper gingival cancers: A National Cancer Database analysis of factors predictive of END and impact on survival.

Authors:  Adetokunbo Obayemi; Jennifer R Cracchiolo; Jocelyn C Migliacci; Qasim Husain; Rahmatullah Rahmati; Benjamin R Roman; Marc A Cohen
Journal:  J Surg Oncol       Date:  2019-09-23       Impact factor: 3.454

6.  Elective neck dissection versus "wait and watch" policy in tongue carcinoma.

Authors:  Satish Kumaran Pugazhendi; Lalitha Thambiah; Anuradha Venkatasetty; Vinod Thangaswamy
Journal:  J Pharm Bioallied Sci       Date:  2012-08

7.  Clinical outcomes with high-dose-rate surface mould brachytherapy for intra-oral and skin malignancies involving head and neck region.

Authors:  Ashwini Budrukkar; Archya Dasgupta; Prakash Pandit; Sarbani Ghosh Laskar; Vedang Murthy; Ritu Raj Upreti; Tejpal Gupta; Kanchan Dholam; Jai Prakash Agarwal
Journal:  J Contemp Brachytherapy       Date:  2017-03-23

8.  Hard Palate Perforation in an Elderly Man With Dementia.

Authors:  Mohsin S Mughal; Ikwinder Preet Kaur; Hafsa Akbar; Syed H Abbas; Priya Angi
Journal:  Cureus       Date:  2021-06-23

9.  Systematic review and meta-analysis of cervical metastases in oral maxillary squamous cell carcinoma.

Authors:  Clemente Chia; Seraphina Key; Zubair Hasan; Sohaib Virk; Faruque Riffat
Journal:  Cancer Rep (Hoboken)       Date:  2021-05-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.